MedPath

A combination of cinacalcet with maxacalcitol for regression of moderate to advanced secondary hyperparathyroidism in patients on chronic hemodialysis

Not Applicable
Conditions
secondary hyperparathyroidism
Registration Number
JPRN-UMIN000001478
Lead Sponsor
Kitano Hospital Division of Nephrology and Dialysis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) Uncontrolled ischemic heart disease, heart failure, and arrhythmia 2) Stroke within 6 months 3) Peripheral artery didease of Fontaine 3 and 4 4) Severe liver cirrhosis 5) Malignancy within 3 years 6) Uncontrolled phychosis 7) Attendant for other clinical studies within 3 months 8) Pregnant woman or man who wish for baby 9) Unsuitable patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath